ECTRIMS eLearning

Fatigue management: Occupational Therapy intervention in Multiple Sclerosis for Argentinean population
ECTRIMS Learn. Saladino M. 10/25/17; 199864; EP1844
María Laura Saladino
María Laura Saladino
Contributions
Abstract

Abstract: EP1844

Type: ePoster

Abstract Category: Therapy - symptomatic - 34 Quality of life

Objective: To provide evidence supporting a biopsychosocial conceptual framework for fatigue management based on Occupational Therapy intervention in Argentinean MS patients and its participation impact.
Design: This is a study analyzing participation impact before and after implementation of a local fatigue management program.
Participants: Fifty-one (N-51) adults with MS who regularly attended a community based, maintenance rehabilitation center.
Main outcomes: Modified Fatigue Impact Scale (MFIS), Functional Independence Measure (FIM), The Community Integration Questionnaire (CIQ), visual-analogue scale.
Results: Regarding age, all patients reduced Fatigue Severity Scale (FSS), MFIS and improved FIM; those older than 46 also increased CIQ (3,5%). Both genders decreased fatigue, furthermore men increased FIM(1,3%) and CIQ(1,2%). Working patients reduced fatigue scales, those working full time also increased FIM (4,6%). Patients with higher education decreased fatigue and improved FIM (1,3%) and CIQ(2,9%). Regarding years since diagnose, both groups decreased fatigue scores and increased FIM (< 12 years 0,5%; >12 years 4,9%), those with less than 12 years also increased CIQ(2,1%). All types of MS reduced their fatigue; MSRR also improved FIM(0,3%) and CIQ(0,2%); MSPP increased FIM(4,6%). Patients without medication decreased FSS, MFIS and improved FIM(4,5%) and CIQ(2,6%). Patients with selective immunosuppressants decreased FSS and MFIS. Those with classic medication reduced the cognitive subscale of MFIS and improved FIM (2,2%). The average level of quality of life satisfaction after our intervention was of 6,86.
Conclusion: Our local Fatigue Management Program applied in Argentinean MS patients has been proven an important and significant tool for OT interventions in all types of MS. Further studies with larger sample sizes are needed.
Disclosure: Nothing to disclose

Abstract: EP1844

Type: ePoster

Abstract Category: Therapy - symptomatic - 34 Quality of life

Objective: To provide evidence supporting a biopsychosocial conceptual framework for fatigue management based on Occupational Therapy intervention in Argentinean MS patients and its participation impact.
Design: This is a study analyzing participation impact before and after implementation of a local fatigue management program.
Participants: Fifty-one (N-51) adults with MS who regularly attended a community based, maintenance rehabilitation center.
Main outcomes: Modified Fatigue Impact Scale (MFIS), Functional Independence Measure (FIM), The Community Integration Questionnaire (CIQ), visual-analogue scale.
Results: Regarding age, all patients reduced Fatigue Severity Scale (FSS), MFIS and improved FIM; those older than 46 also increased CIQ (3,5%). Both genders decreased fatigue, furthermore men increased FIM(1,3%) and CIQ(1,2%). Working patients reduced fatigue scales, those working full time also increased FIM (4,6%). Patients with higher education decreased fatigue and improved FIM (1,3%) and CIQ(2,9%). Regarding years since diagnose, both groups decreased fatigue scores and increased FIM (< 12 years 0,5%; >12 years 4,9%), those with less than 12 years also increased CIQ(2,1%). All types of MS reduced their fatigue; MSRR also improved FIM(0,3%) and CIQ(0,2%); MSPP increased FIM(4,6%). Patients without medication decreased FSS, MFIS and improved FIM(4,5%) and CIQ(2,6%). Patients with selective immunosuppressants decreased FSS and MFIS. Those with classic medication reduced the cognitive subscale of MFIS and improved FIM (2,2%). The average level of quality of life satisfaction after our intervention was of 6,86.
Conclusion: Our local Fatigue Management Program applied in Argentinean MS patients has been proven an important and significant tool for OT interventions in all types of MS. Further studies with larger sample sizes are needed.
Disclosure: Nothing to disclose

By clicking “Accept Terms & all Cookies” or by continuing to browse, you agree to the storing of third-party cookies on your device to enhance your user experience and agree to the user terms and conditions of this learning management system (LMS).

Cookie Settings
Accept Terms & all Cookies